Why are steroids used for a patient with a Discerning Function (DF) score indicating significant liver dysfunction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Steroids for Alcoholic Hepatitis with DF Score ≥32

Corticosteroids (prednisolone 40 mg daily for 28 days) are recommended for patients with severe alcoholic hepatitis defined by a Maddrey Discriminant Function (DF) score ≥32 because they significantly reduce short-term mortality by approximately 30%. 1

Rationale for Using Steroids in Severe Alcoholic Hepatitis

  • Corticosteroids act by reducing the transcription of pro-inflammatory cytokines such as TNF-α, which play a pivotal role in the pathophysiology of alcoholic hepatitis 1
  • Meta-analyses of clinical trials have demonstrated a significant increase in short-term survival among steroid-treated patients compared to controls (84.6% vs 65%), translating to a number needed to treat of 5 1
  • The therapeutic window for steroid treatment is most effective with MELD scores between 25 and 39, where the maximum survival benefit (21-30%) is observed 2

Patient Selection Criteria

  • Steroids are indicated for patients with:

    • DF score ≥32 (primary criterion) 1
    • MELD score >20 (alternative criterion) 1
    • Presence of hepatic encephalopathy (additional indicator) 1
  • Contraindications to steroid therapy include:

    • Uncontrolled infections 1
    • Acute kidney injury with serum creatinine >2.5 mg/dL 1
    • Gastrointestinal bleeding 1
    • Acute pancreatitis 1

Treatment Protocol

  • Prednisolone 40 mg daily for 28 days is the recommended regimen (preferred over prednisone due to impaired conversion of prednisone to prednisolone in liver disease) 1, 3

  • Response to treatment should be assessed at day 7 using the Lille model:

    • Lille score <0.45 indicates good response - continue prednisolone for the full 28 days 1
    • Lille score >0.45 indicates poor response - consider discontinuation of steroids 1
    • Lille score >0.56 indicates null response - steroids should be stopped 1
  • Early change in bilirubin level (ECBL) at day 7 is another indicator of response:

    • Decreased bilirubin at day 7 compared to day 1 predicts better 6-month survival (82% vs 23%) 1

Cautions and Monitoring

  • Patients with hypoalbuminemia may require dose reduction due to decreased protein binding and delayed clearance of prednisolone 3
  • Regular monitoring for infections is crucial as they occur in 12-26% of patients at admission and up to 50% during steroid treatment 1
  • Liver function tests should be monitored every two weeks during treatment 4
  • There may be a ceiling effect where steroids are harmful rather than beneficial at very high DF scores (>54) 1
  • For patients with MELD >51, steroids show no survival benefit 2

Alternative Therapy

  • For patients with contraindications to steroids, pentoxifylline (400 mg orally three times daily for 4 weeks) can be considered 1, 5
  • Pentoxifylline works by inhibiting TNF-α production and has been shown to reduce the incidence of hepatorenal syndrome 1, 5
  • However, pentoxifylline is generally less effective than corticosteroids for improving short-term survival 5

Supportive Care

  • Nutritional support is essential as most patients with severe alcoholic hepatitis are malnourished 1
  • Complete alcohol abstinence must be emphasized as it is the most important factor for long-term survival 1, 5
  • Vitamin and mineral supplementation should be provided to address nutritional deficiencies 1

Remember that while steroids improve 30-day survival in patients with severe alcoholic hepatitis (DF ≥32), their benefit is limited to specific severity ranges, and careful patient selection with close monitoring is essential for optimal outcomes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Corticosteroid pharmacokinetics in liver disease.

Clinical pharmacokinetics, 1979

Guideline

Role of Pentoxifylline in Alcoholic Liver Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.